These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16311001)

  • 1. Evaluation of LC-MS for the analysis of cleaning verification samples.
    Simmonds EL; Lough WJ; Gray MR
    J Pharm Biomed Anal; 2006 Feb; 40(3):631-8. PubMed ID: 16311001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The use of turbulent flow chromatography/mass spectrometry for the rapid, direct analysis of a novel pharmaceutical compound in plasma.
    Ayrton J; Dear GJ; Leavens WJ; Mallett DN; Plumb RS
    Rapid Commun Mass Spectrom; 1997; 11(18):1953-8. PubMed ID: 9450350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel high-throughput automated chip-based nanoelectrospray tandem mass spectrometric method for PAMPA sample analysis.
    Balimane PV; Pace E; Chong S; Zhu M; Jemal M; Pelt CK
    J Pharm Biomed Anal; 2005 Sep; 39(1-2):8-16. PubMed ID: 15978768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validated UPLC method for the fast and sensitive determination of steroid residues in support of cleaning validation in formulation area.
    Fekete S; Fekete J; Ganzler K
    J Pharm Biomed Anal; 2009 Apr; 49(3):833-8. PubMed ID: 19185442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative determination of residual active pharmaceutical ingredients and intermediates on equipment surfaces by ion mobility spectrometry.
    Qin C; Granger A; Papov V; McCaffrey J; Norwood DL
    J Pharm Biomed Anal; 2010 Jan; 51(1):107-13. PubMed ID: 19758781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and efficient approach to reversed-phase HPLC method screening.
    Biswas KM; Castle BC; Olsen BA; Risley DS; Skibic MJ; Wright PB
    J Pharm Biomed Anal; 2009 Apr; 49(3):692-701. PubMed ID: 19181471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of active ingredient within pharmaceutical preparations using flow injection mass spectrometry.
    Wade N; Miller K
    J Pharm Biomed Anal; 2005 Apr; 37(4):669-78. PubMed ID: 15797787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous determination of sulfamethoxazole and trimethoprim in biological fluids for high-throughput analysis: comparison of HPLC with ultraviolet and tandem mass spectrometric detection.
    Bedor DC; Gonçalves TM; Ferreira ML; de Sousa CE; Menezes AL; Oliveira EJ; de Santana DP
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):46-54. PubMed ID: 18243822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel generic UPLC/MS/MS method for high throughput analysis applied to permeability assessment in early Drug Discovery.
    Mensch J; Noppe M; Adriaensen J; Melis A; Mackie C; Augustijns P; Brewster ME
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 847(2):182-7. PubMed ID: 17095304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of liquid chromatography/quadrupole-linear Ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater.
    Bueno MJ; Agüera A; Gómez MJ; Hernando MD; García-Reyes JF; Fernandez-Alba AR
    Anal Chem; 2007 Dec; 79(24):9372-84. PubMed ID: 18001124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chiral purity assay for Flindokalner using tandem mass spectrometry: method development, validation, and benchmarking.
    Young BL; Cooks RG; Madden MC; Bair M; Jia J; Aubry AF; Miller SA
    J Pharm Biomed Anal; 2007 Apr; 43(5):1602-8. PubMed ID: 17298872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cleaning verification assays for highly potent compounds by high performance liquid chromatography mass spectrometry: strategy, validation, and long-term performance.
    Liu L; Pack BW
    J Pharm Biomed Anal; 2007 Mar; 43(4):1206-12. PubMed ID: 17156961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of amiodarone and desethylamiodarone in horse plasma and urine by high-performance liquid chromatography combined with UV detection and electrospray ionization mass spectrometry.
    Maes A; Baert K; Croubels S; De Clercq D; van Loon G; Deprez P; De Backer P
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 May; 836(1-2):47-56. PubMed ID: 16616880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of a generic fast gradient liquid chromatography tandem mass spectrometry method for the analysis of cytochrome P450 probe substrates.
    Ayrton J; Plumb R; Leavens WJ; Mallett D; Dickins M; Dear GJ
    Rapid Commun Mass Spectrom; 1998; 12(5):217-24. PubMed ID: 9519475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
    Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
    J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Capillary electrophoresis-mass spectrometry for impurity profiling of basic pharmaceuticals using non-volatile background electrolytes.
    van Wijk AM; Muijselaar PG; Stegman K; de Jong GJ
    J Chromatogr A; 2007 Aug; 1159(1-2):175-84. PubMed ID: 17588593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced mass resolution method development, validation and assay application to support preclinical studies of a new drug candidate.
    Pucci V; Bonelli F; Monteagudo E; Laufer R
    Rapid Commun Mass Spectrom; 2006; 20(8):1240-6. PubMed ID: 16541410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative determination and sampling of azathioprine residues for cleaning validation in production area.
    Fazio TT; Singh AK; Kedor-Hackmann ER; Santoro MI
    J Pharm Biomed Anal; 2007 Mar; 43(4):1495-8. PubMed ID: 17118615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Separation and quantification of two diastereomers of a Drug Candidate in rat plasma by ultra-high pressure liquid chromatography/mass spectrometry.
    Wang H; Edom RW; Kumar S; Vincent S; Shen Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jul; 854(1-2):26-34. PubMed ID: 17442640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.